Showing results (111-120 of 182) with videos related to
Sort By:
Pageof 19
Biomedical Reports|April 29, 2016
Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancerFaruk Tas, Elif Bilgin, Didem Tastekin, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 23, 2016
Is it solitary plasmacytoma or nonsecretory myeloma? A must-be-solved dilemma?Kayhan Erturk, Didem Tastekin, Gokcen Gundogdu, et al.Journal of Cancer Research and Therapeutics|October 14, 2015
Tongue metastasis of melanomaFaruk Tas, Senem Karabulut, Gulcin Yegen, et al.Cancer Chemotherapy and Pharmacology|October 27, 2015
Elevated circulating monocyte chemoattractant protein 1 (MCP-1/CCL-2) level may be an unfavorable predictive factor to platinum- and taxane-based combination chemotherapy in patients with gastric cancerFaruk Tas, Senem Karabulut, Murat Serilmez, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 21, 2013
Clinical significance of serum insulin-like growth factor-1 (IGF-1) and insulinlike growth factor binding protein-3 (IGFBP-3) in patients with epithelial ovarian cancerFaruk Tas, Senem Karabulut, Murat Serilmez, et al.Medical Oncology (Northwood, London, England)|October 1, 2004
Second-Line docetaxel and gemcitabine combination chemotherapy in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II trialFaruk Tas, Cumhur Demir, Hakan Camlica, et al.Oncology Letters|June 14, 2013
Triplet chemotherapy combination with cisplatin, gemcitabine and docetaxel in patients with chemotherapy-naive advanced non-small cell lung cancerFaruk Tas, Fatma Sen, Nese Guney, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|November 26, 2013
Serum levels of macrophage migration-inhibitory factor (MIF) have diagnostic, predictive and prognostic roles in epithelial ovarian cancer patientsFaruk Tas, Senem Karabulut, Murat Serilmez, et al.BBA Clinical|May 4, 2016
Clinical significance of serum Protease-Activated Receptor-1 (PAR-1) levels in patients with cutaneous melanomaFaruk Tas, Elif Bilgin, Senem Karabulut, et al.Molecular and Clinical Oncology|March 21, 2014
Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survivalFaruk Tas, Fatma Sen, Serkan Keskin, et al.Pageof 19